Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Husam Nawas

Orthopaedic Surgery St. Louis, MO Medical Doctor

NPI 1134319510 CMS profile 5718

12855 North Forty Drive, Suite 125, North Tower, St. Louis, MO 63141

Open in the dashboard

General payments

$18,542

133 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Husam Nawas of St. Louis, MO is reported in the CMS Open Payments database as having received $18,542 across 133 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,688 36
2024 General $5,070 34
2023 General $3,445 33
2022 General $16 1
2021 General $1,798 13
2020 General $144 8
2019 General $2,382 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Husam Nawas
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Husam Nawas were reported at $5,688. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Husam Nawas Orthopaedic Surgery median Middle half National median
2019 $2,382 $644 $140–$2,844 $163
2020 $144 $312 $75–$1,860 $114
2021 $1,798 $520 $117–$2,495 $132
2022 $16 $598 $128–$2,731 $149
2023 $3,445 $461 $128–$2,264 $160
2024 $5,070 $497 $134–$2,475 $164
2025 $5,688 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $5,472 61 payments
  2. Catalyst OrthoScience $4,406 11 payments
  3. Elite Orthopedics, LLC $3,739 13 payments
  4. Smith+Nephew, Inc. $2,279 4 payments
  5. MicroPort Orthopedics Inc $1,732 13 payments
  6. Zimmer Biomet Holdings, Inc. $218 3 payments
  7. Arthrosurface Incorporated $131 1 payment
  8. Arthrex, Inc. $117 1 payment
  9. Flexion Therapeutics, Inc. $83 5 payments
  10. DePuy Synthes Sales Inc. $50 3 payments
  11. Other $314 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $7,195 25 payments
  2. Food and Beverage $4,257 101 payments
  3. Education $3,552 4 payments
  4. Consulting Fee $3,538 3 payments
Products named General payments · program years 2019–2025
  1. HEALICOIL $2,279 4 payments
  2. MAKO $2,235 25 payments
  3. Q-FIX $1,842 3 payments
  4. Bone Anchors with Arthroscopic Delivery System $1,842 3 payments
  5. MPO Hip System $1,638 12 payments
  6. SALVATION $1,635 12 payments
  7. Catalyst CSR Shoulder System $1,300 1 payment
  8. INSIGNIA $1,005 22 payments
  9. TRIATHLON $908 20 payments
  10. Archer 3D Software $666 5 payments
  11. Other $5,153 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

170

Median for Orthopedic Surgery: 203

Drug cost

$750

Median for Orthopedic Surgery: $1,433

Branded share of claims

7.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 83 $380
Diclofenac Sodium Generic 22 $180
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 12 $120
Cephalexin Generic 27 $43
Tramadol Hcl Generic 11 $19
Amoxicillin Generic 15 $7

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$70,973

Of which drugs: $118

Medicare patients

123

Average age 72

Services billed

597

75 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Ischemic heart disease 26%
Diabetes 22%
Depression 21%
Atrial fibrillation 20%
Chronic kidney disease 15%
Osteoporosis 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 28 148 $113

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record